Long intergenic non-protein coding RNA 1150 (LINC01150)

Long intergenic non-protein coding RNA 1150 (LINC01150) is a long non-coding RNA (lncRNA), meaning it does not encode a protein but instead has regulatory roles at the RNA level. Recent studies have identified LINC01150 as an important regulator that promotes proliferation, migration, and invasion of gastric cancer cells; higher expression is associated with poor prognosis in this context[2]. Its mechanism involves acting within a competing endogenous RNA (ceRNA) network, likely by sponging certain microRNAs and thereby modulating downstream gene expression relevant to cancer development. LINC01150 is upregulated in gastric cancer tissues compared with normal tissues and is implicated as a component of a prognostic signature that predicts survival and response to immunotherapy[2]. Current research focuses on its role as a regulatory molecule influencing cancer biology, but it does not represent a canonical receptor, enzyme, or transporter; rather, it is classified as a lncRNA with potential as a biomarker and putative therapeutic target in oncology. There are no known drugs directly targeting LINC01150 at present, and further research will be required to determine its utility in clinical settings[2][1].

Other names

2G7TCONS_00019134